Back to ELVN

Bellevue Group AG → ELVN

Bellevue Group AG ELVN Position History

Enliven Therapeutics, Inc. • Healthcare

Quarters held
3
Latest value
$67.3M
Q3 2026
Peak value
$91M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$91M
Q2 2026$75.6M
Q3 2026$67.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$67.3M1.47M——
Q2 2026$75.6M1.49M——
Q1 2026$91M2.32M——

Other funds holding ELVN

Other Bellevue Group AG positions

RVMDW

REVOLUTION MEDICINES INC

$398.3M
ARGX

ARGENX SE

$386M
IONS

IONIS PHARMACEUTICALS INC

$377.7M
AMGN

AMGEN INC

$350.5M
GILD

GILEAD SCIENCES INC

$312M
VRTX

VERTEX PHARMACEUTICALS INC

$302.6M
AMGN

AMGEN INC

$301.1M
VRTX

VERTEX PHARMACEUTICALS INC

$298M